feed,title,long_url,short_url
Benzinga,Mersana Therapeutics Starts UpRi Dosing In Heavily Pretreated Cohort Of Ovarian Cancer Patients,https://benzinga.com/general/biotech/21/04/20556429/mersana-therapeutics-starts-upri-dosing-in-heavily-pretreated-cohort-of-ovarian-cancer-patients,https://j.mp/3dQFs94
